Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics Calls for Redemption All Outstanding 1-3/4% Contingent Convertible Debentures

12/16/4

Surya N. Mohapatra, Ph.D., Becomes Chairman of Quest Diagnostics

12/15/4

Quest Diagnostics Repurchases 2.7 Million of Its Shares from GlaxoSmithKline; Intends to Call 1-3/4% Contingent Convertible Debentures

12/15/4

Quest Diagnostics Declares Quarterly Cash Dividend

12/14/4

Quest Diagnostics to Speak at the Merrill Lynch Health Services Investor Conference

11/29/4

Quest Diagnostics to Speak at The CIBC World Markets Fifteenth Annual Healthcare Conference

11/05/4

Quest Diagnostics Receives Subpoenas Regarding Test Produced By Subsidiary

10/28/4

Quest Diagnostics Reports Strong Financial Results in Third Quarter 2004

10/25/4

Surya N. Mohapatra, Ph.D. to Become Next Chairman of Quest Diagnostics

10/21/4

Quest Diagnostics' Care360 eMaxx(R) Physician Portal Now Offers Enhanced Electronic Prescribing Services With Online Access to Patients' Pharmacy Benefit Information

10/15/4

Quest Diagnostics Honored as One of Nation's Top 100 Business Technology Innovators By InformationWeek

09/28/4

Quest Diagnostics Joins Dow Jones Sustainability World Index

09/27/4

Quest Diagnostics to Speak at UBS Global Life Sciences Conference

09/27/4

Quest Diagnostics to Offer New Test to Measure Circulating Tumor Cells in Patients With Metastatic Breast Cancer

09/20/4

Quest Diagnostics to Speak at The Banc of America Securities 34th Annual Investment Conference

09/17/4

Quest Diagnostics to Speak at The Thomas Weisel Partners Tailwinds 2004 Conference

09/07/4

New Services on Quest Diagnostics' eMaxx(R) Web Portal to Help Physicians Participate in Pay-for-Performance Programs and Move Physician Practices Toward Clinical Integration

08/23/4

NCQA Receives Three-Year Grant From Quest Diagnostics

07/28/4

Quest Diagnostics Reports Strong Financial Results in Second Quarter 2004

07/22/4

Quest Diagnostics Increases Share Repurchase Authority by $300 Million and Declares Quarterly Cash Dividend

07/22/4

Increased Use of Amphetamines Linked to Rising Workplace Drug Use, According to Quest Diagnostics' 2003 Drug Testing Index

07/22/4

Top Ranking By KLAS Enterprises For Electronic Patient Record Solution Awarded To Quest Diagnostics' MedPlus(TM) Subsidiary

07/14/4

Quest Diagnostics to Speak at The Wachovia Securities' Fourteenth Annual Nantucket Conference

06/23/4

Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 6.0

06/15/4

Quest Diagnostics Enters Into an Agreement with Express Scripts to Provide Physicians with Enhanced ePrescribing Capabilities

06/09/4

Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference

06/08/4

Diagnostics Leaders Collaborate to Help Physicians Better Differentiate Allergy-Like Symptoms

05/18/4

Quest Diagnostics to Speak at the Banc of America Securities Health Care Conference

05/18/4

Quest Diagnostics Signs Multi-Year Agreement with TriPath Imaging To Launch SurePath(TM) Liquid-Based Pap Test Nationally

05/06/4

Quest Diagnostics to Speak at The Morgan Stanley Second Annual Global Healthcare Unplugged Conference

05/05/4

Surya N. Mohapatra, Ph.D., Appointed CEO of Quest Diagnostics

05/04/4

Quest Diagnostics Declares Quarterly Cash Dividend

05/04/4

Quest Diagnostics Offers Gene-Based Test for Congenital Adrenal Hyperplasia

05/04/4

Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2004

04/22/4

Quest Diagnostics to Complete CEO Transition on May 4, 2004

04/22/4

John C. Baldwin, M.D., Nominated for Election to Quest Diagnostics Board of Directors

04/13/4

Quest Diagnostics and Medco Health Solutions Launch Initiative to Increase Use of ePrescribing

03/15/4

Quest Diagnostics' Healthcare Information Technology Subsidiary, MedPlus, Enters Into an Agreement with SureScripts to Provide Physicians With Electronic Prescribing Capabilities

02/25/4

Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference

02/23/4

Quest Diagnostics Declares Quarterly Cash Dividend

02/19/4

Quest Diagnostics to Speak at UBS Global Healthcare Services Conference

02/03/4

Quest Diagnostics to Speak at U.S. Bancorp Piper Jaffray Health Care Conference

01/27/4

Quest Diagnostics Announces Strong Revenue and Earnings Growth For Fourth Quarter and Full Year 2003

01/27/4

Quest Diagnostics to Speak at the 22nd Annual JPMorgan Healthcare Conference

01/09/4